New spinal zap device aims to quiet chronic nerve pain
NCT ID NCT07154056
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new type of spinal cord stimulation to help people with long-lasting nerve pain that hasn't improved with other treatments. About 17 adults will receive the stimulation and be followed for 6 months. The goal is to see if it safely reduces pain and improves daily life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 17 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subject has ≥ 18 years and ≤ 80 years * Subject has a global Visual Analogic Scale ≥ 5 * Subject has non-cancer pain with a significant neuropathic component for at least 6 months. * Subject has stable pain for at least 30 days * Pain medication(s) dosage(s) is/are stable for at least 30 days * Subject is eligible for Spinal Transforaminal NeuroStimulation after a pre-implantation assessment by a multidisciplinary team, as described by the French National Authority for Health (Haute Autorité de Santé) * Subject understands and accepts the constraints of the study and is able to use the equipment. * Patient is covered by French national health insurance. * Subject has given written consent to the study after having received clear and complete information. Non-inclusion Criteria: * Subject has a coagulation disorder * Subject is or has been treated with SCS, subcutaneous or peripheral nerve stimulation, an intrathecal drug delivery system * Subject has had corticosteroid therapy within the past 30 days * Subject has had radiofrequency therapy within the past 3 months * Subject has been diagnosed with cancer in the past 2 years * Subject has had a spinal surgery within the past 6 months * Simultaneous participation to any interventional study on health product or any study able to interfere with the current study endpoints. * Subject has at least one of brain MRI contraindications such as : intracranial clips /Vascular clips/Pace maker/Heart battery, Defibrillator, Implanted Holter (REVEAL type), Neuro-stimulator not compatible with 1.5 T MRI/Stents/ Coils/Cardiac valves (heart)/ Shunt valve/Implanted injection pump/Cochlear implants/Implantable chamber (PAC)/Intracorporeal metal shards/ metallic foreign bodies, the location and the presence of implanted neurostimulation components that are not listed as MRI Conditional, cardiac implantable electronic device, metallic intraocular foreign bodies, cochlear implants, drug infusion pumps, catheters with metallic components, cerebral artery aneurysm clips, magnetic dental implants, tissue expander, artificial limb, hearing aid, piercing. * Subjects requiring closer protection, i.e. minors, subjects deprived of their freedom by a court or administrative decision, subjects admitted to a health or social welfare establishment, major subjects under legal protection, and finally patients in an emergency setting * Pregnant or breastfeeding women, women at age to procreate and not using effective contraception.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic neuropathic pain are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Poitiers University Hospital
RECRUITINGPoitiers, France, 86000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping nerves without a scalpel: can radiofrequency quiet chronic pain?
- Can a brain wave reading reveal who benefits from spinal cord stimulation?
- Could a quick brain zap ease Long-Term nerve pain?
- Could a tiny dose of naltrexone ease HIV nerve pain without opioids?
- Magnetic pulses to the brain may ease stubborn nerve pain
- Brain zaps may ease stubborn back pain without drugs